| 
Spin Control: SMBs that develop software for their own needs know potential markets from the inside, but there's more to consider for a successful spin-off
For almost a year, Owen Barrett and Craig Robertson searched to no avail for an affordable software tool to help manage and integrate the business processes of their small company.
Team NEO hires executive to recruit Innovation Center businesses
Team NEO and the Cleveland Clinic are joining forces to attract bioscience and medical-device companies for the yet-to-be-built Global Cardiovascular Innovation Center on the hospital system's main campus.
Cleveland cardiologists discover clue in good-cholesterol puzzle
A team of cardiologists from Cleveland discovered an important clue as to why the protein that ferries so-called good cholesterol in and out of cells doesn't always leave with its cargo intact.
Brain surgery changes broker's outlook on advice
Forty-one years after he enlisted in the Army during the Vietnam era, Hunter Smith sports the same haircut — this time after surgery to implant electrodes and a brain pacemaker that have alleviated tremors of Parkinson’s disease that plagued the 61-year-old Charleston stockbroker.
Clinic NanoMed program gets $1 million grant
The Cleveland Clinic’s NanoMedicine Program has received a $1 million grant from a nanotechnology company to create and test pharmaceutical compounds to treat degenerative diseases and some cancers.
Cleveland Clinic part of new cardiac surgery clinical trials network
Heart bypasses are on the decline, but the lucrative and evolving field of cardiac surgery is busier than ever, prompting the government to create an unusual clinical trials network that will look at which novel surgical techniques work best in which patients.
AcelleRX Therapeutics receives initial financing; company preparing for phase 1 clinical trial of chronic heart failure treatment
AcelleRX Therapeutics, Inc., a Cleveland Clinic start up company, that develops regenerative medicine technologies for treatment of cardiovascular disease and other ischemic disorders, today announced the company received its first round of private funding.
Third Frontier program invests about $300 million in Northeast Ohio Granting
The Third Frontier Project is beginning to reap big returns in Northeast Ohio.
Quantum dots outline brain tumors for surgical removal
Although surgical removal of a tumor can be the most effective way of treating brain cancer, neurosurgeons are often faced with the dilemma of determining the exact border between a tumor and the healthy tissue that surrounds it.
Intelect Medical wins $7 million from device makers
Intelect Medical Inc., the Cleveland Clinic spinoff that is developing systems to modulate brain activity, has closed a financing round with $7 million from Boston Scientific Corp. and Greatbatch Inc.
Electrical pulses 'rouse' patient: Deep brain stimulation with electrical pulses may offer hope for patients trapped in a minimally conscious state
Treatment of a 38-year-old man with a severe brain injury enabled him to use words and gestures, chew and swallow and drink from a cup, say US doctors.
Cleveland case study: Going from a tech transfer laggard to the top 10
Cleveland is becoming a hotbed of successful research commercialization, and tech transfer professionals are getting the lion's share of the credit.
Bioscience bosses break bread with Hungary: Proficiency in research, commercialization deficiency make country ripe for partnership
Northeast Ohio's bioscience community is expanding its circle of overseas friends.
Cleveland BioLabs compound could be breakthrough
A compound being commercialized by Cleveland BioLabs Inc. helped regenerate bone marrow stem cells in mice that received transplants.
The TIME 100: Steven Nissen
In some ways, Steve Nissen's undergraduate years at the University of Michigan - which included crusading against the Vietnam War - were the toughest period of his life.
Region on par with peers for invention disclosures
Cleveland might not have the warm weather of Research Triangle, North Carolina, or an Ivy League university like Boston, but its doctors and professors are keeping up with their peers when it comes to inventions.
Clinic doctor on prestigious Time 100 list: Nissen one of the most influential people in world
He is a former war protester who became chief of cardiology at one of the world's premier hospitals.
From ideas to inventions: Medical Device Solutions turns Clinic docs', researchers' dreams into concrete designs
Brian Davis jokes that his feet might end up beating a path between the Cleveland Clinic and its technology commercialization office.
Clinic's CCF Innovations licensing revenues triple to reach $9.9M
One-time deals helped the Cleveland Clinic's technology commercialization arm triple its licensing income in 2005, but the spike in revenue won't be a one-time increase over levels from previous years, according to the organization's director.
Cleveland BioLabs raises $30 million
Cleveland BioLabs Inc. has raised $30 million from accredited investors in a private placement of 4.3 million shares of Series B convertible preferred stock.
Cleveland Clinic awarded four new patents for new medical devices
Cleveland Clinic recently received four U.S. patents for innovations in ophthalmology, cardiology and for developing a support pad for surgical patients.
Technology to go: The CCF Innovations unit at the Cleveland Clinic turns medical ideas into businesses
Several years ago, Dr. Mark Penn and his colleagues at the Cleveland Clinic were trying to figure out why certain stem cells target the heart.
View more
in the press releases archive
|
